Download presentation
Presentation is loading. Please wait.
Published byMalcolm Lane Modified over 8 years ago
1
Jennifer M. Finefield Robert M. Williams, Advisor Colorado State University December 6, 2011 Selective HDAC Inhibitor Novel Drug Delivery Method Biosynthetic Studies
2
Efforts Toward the Synthesis of a Selective Histone Deacetylase Inhibitor
3
DNA Packaging For DNA to fit within the nucleus, it must be condensed DNA is packaged into chromatin To begin packaging, DNA is wound around histones www.med.unc.edu www.christopher_vidal.com
4
Gene Expression: Dynamic Wrapping and Unwrapping of DNA Histone Acetyltransferase (HAT) readies DNA for transcription Histone Deacetylase (HDAC) returns DNA to the inactive state HDAC inhibitors prevent removal of acetyl residues X www.med.unc.edu www.christopher_vidal.com
5
Transcriptional Control HDAC inhibitors mimic the natural substrate Deacetylation is prevented, eventually leading to cell death
6
Zn-Dependent Histone Deacetylase Enzymes HDAC enzymes are divided into different classes Within each class, there are different isoforms Many known HDAC inhibitors display very little selectivity for class or isoform Marks, P. A., et al., Advances in Cancer Research, 2005, 137
7
HDAC Inhibitors and Enhancing Selectivity Many known HDAC inhibitors display very little selectivity for class or isoform Wiest, O. et al., J. Med. Chem. 2004, 47, 3409; Methot, J. L., et al., Bioorg. Med. Chem. Lett. 2008, 18, 973
8
Improving Selectivity of HDACi: Targeting HDAC1 and HDAC2 Moradei, O. M., et al., J. Med. Chem. 2007, 50, 5543
9
Improving Selectivity of HDACi: Targeting HDAC3 Finefield, J. M.; Williams, R. M.; Wiest, O.; Bradner, J. Unpublished results
10
Improving Selectivity of HDACi: Targeting HDAC3 Finefield, J. M.; Williams, R. M.; Wiest, O.; Bradner, J. Unpublished results Ser118, present in HDAC1/2 (green) » Tyr118 in HDAC3 (blue)
11
Key Disconnections
12
Thiazoline-Pyridine Synthesis Bowers, A., et al., Org. Lett., 2009, 11, 1301
13
Synthesis of the Amide Isostere Bowers, A., et al., J. Am. Chem. Soc., 2009, 131, 2900
14
Alternate Route
15
2-Thiophenyl Biaryl Synthesis
16
Final Steps and Future Direction ______________________________________________________________________________________________________________________________
17
Design and Synthesis of a Novel Drug Delivery Method Specifically Targeted to Multiple Myeloma Cells
18
Multiple Myeloma MM is a plasma cell malignancy that can lead to bone destruction, anaemia, hypercalcaemia, and renal insufficiency MM is associated with older age (median age 66 years) and is found to occur more often in men than women Cause of MM remains unknown Current treatments include a single high-dose of melphalan, velcade, and various combination treatments Trialx.com, Mahindra, A., et al., Blood Reviews 2010, 24, S5; Barlogie, B., et al., Blood 2004, 103, 20
19
Tumor Specific Oligonucleotide (MB8226) UAGGCUACGUACUUAAGCG
20
The Trojan Horse Nakatani, K. et al., J. Am. Chem. Soc. 2000, 122, 2172
21
Naphthyridine Modified MM Drugs Currently undergoing clinical trials to be used as a combination treatment for multiple myeloma Given either as a high-dose treatment or as part of a combination for the treatment of multiple myeloma
22
Naphthyridine Modified Vorinostat Brown, E. V., J. Org. Chem. 1965, 30, 1607; Yoshida, M. et al., Synthesis 2008, 1099; Gediya, L. K. et al. J. Med. Chem. 2005, 48, 5047
23
Naphthyridine Modified Vorinostat Mai, A. et al. OPPI Briefs 2001, 33, 391
24
Naphthyridine Modified Melphalan Nakatani, K. et al., Bioorg. Med. Chem. 2003, 11, 2347; Gullbo, J. et al., Oncol. Res. 2003, 14, 113
25
Preliminary Test Results
27
Studies on the Biosynthesis of Reverse Prenylated Indole Secondary Metabolites from Aspergillus versicolor and Aspergillus sp. MF297-2
28
Reverse Prenylated Indole Secondary Metabolites 1969-2006
29
Proposed Biosynthesis of the Bicyclo[2.2.2]diazaoctane Ring System Porter and Sammes Diels-Alder Proposal (1970) Enzymatic Diels-Alder Reaction Porter, A. E. A. et al., Chem. Commun. 1970, 1103; Williams, R. M., Chem. Pharm. Bull. 2002, 50, 711.
30
Proposed Biosynthesis of the Bicyclo[2.2.2]diazaoctane Ring System Enzyme Controlled Stereoselectivity
31
Reverse Prenylated Indole Secondary Metabolites 2007-2011
32
Isolation of the Notoamides: New Addition to the Stephacidin Family 2007: Aspergillus sp. MF297-2 Kato, H. et al., Angew. Chem. Int. Ed. 2007, 46, 2254
33
Isolation of the Notoamides: New Addition to the Stephacidin Family 2008: Aspergillus versicolor NRRL 35600 Greshock, T. J. et al., Angew. Chem. Int. Ed. 2008, 47, 3573
34
Antipodal Natural Products Tsukamoto, S. et al., Org. Lett. 2009, 11, 1297; Greshock, T. J. et al., Angew. Chem. Int. Ed. 2008, 47, 3573
35
Isolation of the Notoamides: New Addition to the Stephacidin Family 2008-2010: Aspergillus sp. MF297-2 Tsukamoto, S. et al: JACS, 2009, 131, 3834; JNP 2008, 71, 2064; OL 2009, 11, 1297; JNP 2010, 73, 1438
36
Isolation of Notoamide E: A Potential Biosynthetic Precursor 2008-2010: Aspergillus sp. MF297-2 Tsukamoto, S. et al., J. Am. Chem. Soc. 2009, 131, 3834
37
Proposed Biosynthetic Pathway: Notoamide E Greshock, T. J. et al., Angew. Chem. Int. Ed. 2008, 47, 3573
38
Synthesis of [ 13 C] 2 -Notoamide E Tsukamoto, S. et al., JACS 2009, 131, 3834; Grubbs, A. W. et al., TL 2005, 46, 9013; Grubbs, A. W. et al., ACIE 2007, 46, 2257
39
Synthesis of [ 13 C] 2 -Notoamide E Tsukamoto, S. et al., J. Am. Chem. Soc. 2009, 131, 3834
40
[ 13 C] 2 -Notoamide E Incorporation Study with Aspergillus sp. MF297-2 No labeled bicyclo[2.2.2]diazaoctane containing metabolites were produced Tsukamoto, S. et al., J. Am. Chem. Soc. 2009, 131, 3834
41
[ 13 C] 2 -Notoamide E Incorporation Study with Aspergillus versicolor Finefield, J. M.; Williams, R. M. et al., Tetrahedron Lett. 2011, 52, 1987
42
Possible Precursors Leading to Stephacidin A
43
Synthesis of Deoxybrevianamide E and 6-Hydroxydeoxybrevianamide E Kato, H.; Nakamura, Y.; Finefield, J. M.; Umaoka, H.; Nakahara, T.; Williams, R. M.; Tsukamoto, S., TL 2011, 52, 6923
44
Synthesis of Ketopremalbrancheamide
45
Biosynthetic Breakthrough: Characterization of the ( )-Notoamide Biosynthetic Gene Cluster Ding, Y.; de Wet, J. R.; Cavalcoli, J.; Li, S.; Greshock, T. J.; Miller, K. A.; Finefield, J. M.; Sunderhaus, J. D.; McAfoos, T. J.; Tsukamoto, S.; Williams, R. M.; Sherman, D. H., JACS 2010, 132, 12733
46
Biosynthetic Breakthrough: Identification of Two Prenyltransferases Ding, Y.; de Wet, J. R.; Cavalcoli, J.; Li, S.; Greshock, T. J.; Miller, K. A.; Finefield, J. M.; Sunderhaus, J. D.; McAfoos, T. J.; Tsukamoto, S.; Williams, R. M.; Sherman, D. H., JACS 2010, 132, 12733
47
Early Steps in the Biosynthetic Pathway
48
Feeding Study with [ 13 C] 2 -[ 15 N]-6- Hydroxydeoxybrevianamide E No incorporation into advanced metabolites Finefield, J. M.; Williams, R. M. et al., JOC 2011, 76, 5954; Finefield, J. M.; Williams, R. M.; Tsukamoto, S. et al., TL 2011, 52, 6923
49
Possible Enantio-diverging Pathways from Notoamide S
50
Notoamide S Incorporation Study with Aspergillus versicolor Unlabeled synthesis of notoamide S: McAfoos, T. J. et al., Heterocycles 2010, 82, 461 Results from feeding study: Finefield, J. M.; Tsukamoto, S.; Williams, R. M. et al., unpublished results
51
Notoamide S Incorporation Study with Aspergillus sp. MF297-2 Tsukamoto, S. et al., unpublished results
52
Notoamide S: Additional Biosynthetic Insight
53
Notoamide T: Precursor Incorporation Studies ________________________________________________________________________________________________________________________________ Finefield, J. M., Tsukamoto, S.; Williams, R. M. et al., unpublished results
54
Notoamide S: Additional Biosynthetic Insight
55
Biosynthetic Precursor Incorporation Study ________________________________________________________________________________________________________________________________ Finefield, J. M.; Tsukamoto, S.; Williams, R. M. et al., Org. Lett. 2011, 13, 3802
56
Characterization of the ( )-Notoamide Biosynthetic Gene Cluster ( )-Notoamide Biosynthetic Gene Cluster (+)-Notoamide Biosynthetic Gene Cluster Li, S.; Sherman, D. H. et al., unpublished results
57
Current Postulated Biogenesis of the Notoamides and Stephacidins
58
Summary
59
Acknowledgements Prof. Robert M. Williams Williams Research Group Prof. David H. Sherman Sherman Research Group Prof. Sachiko Tsukamoto Tsukamoto Research Group Dr. James Berenson
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.